Stay updated on Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial page
- Check5 days agoChange DetectedRecruitment status now shows no further participant enrollment; new help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label formatting was adjusted, with the revision updated to v3.6.0.SummaryDifference0.4%

- Check12 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing Revision: v3.5.4. This indicates a small update to the page's underlying revision rather than a change to study details.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 on the page, signaling a new release of the site rendering. The content and study details remain unchanged aside from metadata.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page footer revision label has been updated from **Revision: v3.5.0** to **Revision: v3.5.3**.SummaryDifference0.0%

- Check91 days agoChange DetectedThe page now shows a revision label, Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

- Check106 days agoChange DetectedThe page now displays the latest revision label (v3.4.3) and removes the previous revision (v3.4.2).SummaryDifference0.0%

Stay in the know with updates to Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial page.